[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"content-doc-dcio9e8888aa":3},{"user":4,"document":8,"mainDocument":27,"columnUrl":29,"subscription":30,"footer":42,"text":80},{"isAuthenticated":5,"isAdmin":5,"displayName":6,"avatarUrl":6,"nid":6,"groupLevel":7},false,"",-10,{"id":9,"fullTitle":10,"subTitle":6,"url":11,"columnId":12,"columnName":13,"columnUrl":14,"summary":6,"contentHtml":15,"mainContentHtml":6,"posterUrl":16,"createDate":17,"displayDate":18,"displayDateSlash":19,"pageviews":20,"tags":21,"hidden":5,"isSubContent":5,"replyDocOrTargetId":6,"contentType":23,"videoId":6,"liveVideoUrl":6,"useContentVideo":5,"duration":24,"price":24,"priceText":25,"priceBadgeText":25,"priceBadgeClass":26,"freeForMinGroupLevel":24,"redirectUrl":6,"readyToStream":5},"dcio9e8888aa","新冠疫苗海外销售强劲：Moderna(MRNA)Q3扭亏为盈，大幅上调全年营收指引","\u002Fdoc\u002Fdcio9e8888aa","col18178739ee","美股资讯","\u002Fcol\u002Fcol18178739ee","\u003Cp>\n\u003C\u002Fp>\u003Cp>\u003Cspan>美股投资网获悉，11月6日美股盘前，Moderna(MRNA)公布 2026 年第三季度业绩。财报显示，该公司总营收 13.13 亿美元，同比增长 29%，远高于市场预期的约 8.85 亿美元；净利润 1.62 亿美元，较去年同期的净亏损 2 亿美元实现扭亏；摊薄每股收益 0.38 美元，大幅优于市场预期的每股亏损 1.25 美元。\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003Cspan>该公司表示，营收增长主要由新冠疫苗在国际市场的强劲销售，以及英国、加拿大、澳大利亚等长期战略政府合作订单的交付驱动。当季美国市场营收 7.8 亿美元，国际市场营收 5.33 亿美元。\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003Cspan>盈利端同步改善销售成本 3.18 亿美元(同比增长 54%，含 6500 万美元第三方特许权使用费)；研发费用 5.83 亿美元，同比降低 27%，主因部分传染病管线后期临床研究收尾及组织降本增效;经营利润 1.30 亿美元，去年同期为经营亏损 2.60 亿美元。\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003Cspan>截至 9 月底，现金及投资 80 亿美元，环比增加，主要来自 26 亿美元可转债发行净收益，部分被 9.5 亿美元诉讼和解支出及季节性营运资金占用抵消。\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003Cspan>公司上调全年指引，2026 年营收增速由此前\"至多 10%\"大幅上调至 15%–25%，预计营收约一半来自美国、一半来自国际市场；研发费用指引由约 29 亿美元下调至约 27 亿美元；年末现金及投资指引由 47 亿–52 亿美元上调至 81 亿–83 亿美元。\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003Cspan>业务与管线方面，CEO Stéphane Bancel 表示公司已获批五款产品8 月流感疫苗 mFLUSIVA 获美国 FDA 批准(适用于 50–64 岁，65 岁及以上获加速批准)，加拿大亦获批;流感\u002F新冠联合疫苗 mCOFLU 在加拿大获批(欧盟品牌 mCOMBRIAX)，仍待日本、英国、澳大利亚等地审评。\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003Cspan>肿瘤管线中，与默沙东合作的个体化癌症疫苗 intismeran 在黑色素瘤三期临床取得积极结果(数据显示联合 Keytruda 可将复发或死亡风险降低 42%)。不过诺如病毒疫苗 mRNA-1403 三期中期分析未达早期成功标准，公司本季不再新增研究队列。\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003Cspan>Moderna 股价近期因黑色素瘤数据从 52 周低点 22.28 美元大幅反弹至 220 美元上方。\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003Cspan>最专业的美股资讯,推荐美股大数据 \u003Ca href=\"https:\u002F\u002FStockwe.com\u002F\">https:\u002F\u002FStockwe.com\u002F\u003C\u002Fa>\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003Cspan>如何识别美股市场异常波动？美国机构主力资金买卖情况，出货和吸筹，使用美股投资网VIP会员，2008年成立于美国硅谷，由前纽约证券交易所分析师Ken创立，联合多位摩根斯坦利分析师，谷歌 Meta工程师利用AI和大数据，配合十多年美股实战经验和业内量化模型，建立了一个股市数据库 \u003Ca href=\"https:\u002F\u002FStockWe.com\u002F\">https:\u002F\u002FStockWe.com\u002F\u003C\u002Fa> 每天处理千万级股票数据：捕捉期权大单，实时主力资金流向、机构持仓变化、川普突发新闻，精准交易信号第一时间发到您手机APP！\u003C\u002Fspan>\u003C\u002Fp>\n\u003Cp>\u003C\u002Fp>","https:\u002F\u002Fwww.tradesmax.com\u002Fimages\u002Fa_Stock\u002FM\u002FMRNA\u002FMRNA.jpg","2026-11-06T13:41:59","2026.11.06","2026\u002F11\u002F06",36093,[22],"MRNA","Article",0,"免费","success",{"id":9,"fullTitle":10,"subTitle":6,"url":11,"columnId":12,"columnName":13,"columnUrl":14,"summary":6,"contentHtml":15,"mainContentHtml":6,"posterUrl":16,"createDate":17,"displayDate":18,"displayDateSlash":19,"pageviews":20,"tags":28,"hidden":5,"isSubContent":5,"replyDocOrTargetId":6,"contentType":23,"videoId":6,"liveVideoUrl":6,"useContentVideo":5,"duration":24,"price":24,"priceText":25,"priceBadgeText":25,"priceBadgeClass":26,"freeForMinGroupLevel":24,"redirectUrl":6,"readyToStream":5},[22],"\u002Fcol\u002Fstocknews",{"visible":5,"marketingHtml":31,"services":32,"recentDocuments":41},"\u003Cfigure class=\"image\">\u003Ca href=\"https:\u002F\u002Fstockwe.com\u002Fdoc\u002Fdcio537efad5\" rel=\"noopener noreferrer\">\u003Cimg src=\"\u002Fimg\u002Fstockwewebfiles\u002Fweb-202408-stk\u002F1586109431mceclip0.jpg\">\u003C\u002Fa>\u003C\u002Ffigure>\u003Cdiv class=\"text-center\">\u003Ch2 class=\"card-title mx-auto\">\u003Cbr>\u003Ca rel=\"noopener noreferrer\" href=\"https:\u002F\u002Fstockwe.com\u002Fdoc\u002Fdcio537efad5\">案例介绍：英伟达深度研究报告\u003C\u002Fa>\u003C\u002Fh2>\u003C\u002Fdiv>",[33,37],{"productId":34,"serviceName":35,"priceText":36},"prod_PPxdDdK87QaiLv","月付","$12.95美元",{"productId":38,"serviceName":39,"priceText":40},"prod_PPxeMs3bix1da5","年付","$149.00美元",[],{"links":43,"images":71,"summaryHtml":76,"aboutTitle":77,"aboutHtml":78,"copyrightHtml":79},[44,47,50,53,56,59,62,65,68],{"label":45,"url":46},"深度报告","\u002Fcol\u002FdepthReport",{"label":48,"url":49},"VIP会员","\u002Fvip",{"label":51,"url":52},"期权推荐","\u002FOption",{"label":54,"url":55},"低价暴涨股","\u002FPenny",{"label":57,"url":58},"AI智能体","\u002FAiAgent",{"label":60,"url":61},"常见问题","https:\u002F\u002Fstockwe.com\u002FFAQ",{"label":63,"url":64},"美股课程","\u002Fcol\u002Fvideos",{"label":66,"url":67},"免责声明","\u002Fdisclaimer",{"label":69,"url":70},"联系我们","\u002FContactUs",[72,73,74,75],"\u002Fimages\u002Ffooter\u002Ffooter-1-wechat.gif?v=20260930c","\u002Fimages\u002Ffooter\u002Ffooter-2-telegram.png?v=20260930c","\u002Fimages\u002Ffooter\u002Ffooter-3-whatsapp.png?v=20260930c","\u002Fimages\u002Ffooter\u002Ffooter-4-line.png?v=20260930c","邮箱: buy@TradesMax.com 美国电话 626-378-3637","公司介绍","\u003Cp class=\"MsoNormal\">美股大数据 \u003Ca href=\"https:\u002F\u002Fstockwe.com\" rel=\"noopener\">StockWe.com\u003C\u002Fa> 是一个美国领先的金融和美股信息大数据提供商，紧盯华尔街金融市场和行情，2008年成立于美国硅谷，创始人是前纽约证券交易所资深分析师Ken，联合多位摩根斯坦利分析师，谷歌 Meta工程师利用AI和大数据，配合十多年美股实战经验和业内量化交易模型，每天处理海量股票数据：挖掘潜力大牛股，捕捉期权异动大单，实时主力资金流向、机构持仓变化、川普突发新闻，美股买卖信号第一时间发到您手机APP。\u003C\u002Fp>","专业美股投资者都在这里",{"loading":81,"search":82,"searchPlaceholder":82,"hotContent":83,"draft":84,"noData":85,"searchNoData":86,"courseContent":87,"more":88,"buyNow":89,"subscribeNow":90,"encoding":91,"paidContent":92},"Loading...","搜索","热门内容","草稿","目前没有任何内容公布","当前检索内容没有数据","课程内容","更多","立即购买后观看","- 立即订阅 -","视频编码中...","付费内容"]